OxThera
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Total raised
€74M
€74,350,000
Funding rounds
4
Investors
6
distinct backers
Active since
2005-06
latest 2016-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood13
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-11-01 | Other | €32M | Industrifonden,LSP,Sunstone Capital,Ysios Capital | View deal → |
| 2014-04-01 | Other | €7.7M | IDInvest Partners | View deal → |
| 2007-06-01 | Other | €17M | HealthCap | View deal → |
| 2005-07-01 | Other | €18M | HealthCap | View deal → |